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Abstract
We analyzed nucleotide changes in 3 genes, ARIX, PHOX2B, and KIF21A, in 6 patients
of 3 families with congenital superior oblique muscle palsy. Three exons of ARIX, 3 exons of
PHOX2B, and exons 8, 20, and 21 of KIF21A were amplified by polymerase chain reaction from
genomic DNA isolated from the peripheral blood. The DNA fragments were directly sequenced in
both directions. In 2 different families, a heterozygous nucleotide change, ARIX 153G>A, in the
5’-untranslated region was found in common between a father and daughter with muscle palsy and
between a mother and daughter with muscle palsy (Family No. 1 and No. 3). In the other family
(Family No. 2), a heterozygous 15-nucleotide deletion, PHOX2B 1124del15, resulting in loss of
5 alanine residues in the alanine repeat of the protein, was found in the daughter with muscle
palsy and her father with normal traits, but was not found in the mother with muscle palsy. No
KIF21A nucleotide change was found in any patients. The ARIX 153G>A polymorphism might
be a genetic risk factor for the development of congenital superior oblique muscle palsy.
KEYWORDS: ARIX, PHOX2B, KIF21A, congenital superior oblique muscle palsy, familial
(hereditary) disease
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trabismic syndromes,  characterized by con-
genital limitation of eye movements from abnor-
mal innervation of the extraocular muscles,  have 
recently been grouped as congenital cranial dysinner-
vation disorders [1,  2].  These conditions include 
Duane retraction syndrome,  congenital ﬁ brosis of the 
extraocular muscles (CFEOM),  congenital oculomotor 
nerve palsy,  Mobius syndrome,  double elevator palsy,  
and congenital horizontal gaze palsy.
　 Congenital superior oblique muscle palsy is the 
most common isolated cranial nerve palsy and has been 
considered a neurogenic palsy among the congenital 
cranial dysinnervation disorders [2].  The clinical 
features of congenital superior oblique muscle palsy 
are hypertropia (upward deviation of the eye),  ocular 
motility disorders such as underaction of the superior 
oblique muscle and overaction of the unopposed antag-
onist inferior oblique muscle,  abnormal head posture 
such as head tilt toward the non-paralyzed side,  the 
presence of large vertical fusional amplitudes,  and 
sometimes amblyopia in the non-dominant eye.  The 
etiology of congenital superior oblique muscle palsy 
remains basically unknown.  Anatomical abnormalities,  
recorded to date in patients with congenital superior 
oblique muscle palsy,  include aplasia of the trochlear 
nucleus,  the absence or hypoplasia of the tendon and/
or muscles [3ﾝ8],  and orbital pulley structure anoma-
lies [9].  On rare occasions,  congenital superior 
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oblique muscle palsy shows familial occurrence and 
follows an autosomal dominant mode of inheritance 
[10ﾝ14].
　 Understanding of the genetics of congenital cranial 
dysinnervation disorders has advanced in recent years.  
KIF21A gene mutations have been identiﬁ ed in patients 
with CFEOM type 1 [15ﾝ18],  which shows an auto-
somal dominant trait and is associated with the 
absence of the superior branch of the oculomotor 
nerve.  ARIX gene mutations have been found in 
patients with CFEOM type 2 [19,  20],  which shows 
an autosomal recessive trait and is proposed to result 
from aberrant development of the oculomotor and 
trochlear nerve and nuclei in the brainstem [21].
　 Based on the working hypothesis that congenital 
superior oblique muscle palsy might be a clinically 
milder variant of CFEOM type 2,  we previously ana-
lyzed ARIX and PHOX2B gene polymorphisms in 
patients with congenital superior oblique muscle palsy 
[22,  23].  The PHOX2B gene is a homologue of the 
ARIX gene,  100ｵ identical to ARIX in the homeodo-
main region and 75ｵ identical in the brachyury-like 
domain [19].  In this study,  we described clinical fea-
tures in 3 small families with congenital superior 
oblique muscle palsy,  and examined polymorphisms of 
the ARIX,  PHOX2B and KIF21A genes in patients of 
the families.
Materials and Methods
　 Genomic DNA from members of three families with 
congenital superior oblique muscle palsy (Fig.  1) was 
used for the study.  The diagnosis of superior oblique 
muscle palsy was based on the presence of hypertro-
pia (upward deviation of the eye) on the aﬀ ected para-
lyzed side,  which became greatest in the gaze toward 
the nasal ﬁ eld of the involved eye.  The additional 
diagnostic feature was a positive Bielschowsky head 
tilt test,  showing an upward deviation of the involved 
eye when the head is tilted toward the aﬀ ected para-
lyzed side (Fig.  2).  In the congenital cases,  these 
features were present from birth and other causative 
factors such as trauma were absent.  The study was 
approved by the Institutional Review Board at 
Okayama University Medical School,  and written con-
sent was obtained from each patient or a parent when 
the patient was below age 15.  All of the procedures 
conformed to the Declaration of Helsinki.
　 Brieﬂ y,  peripheral leukocytes were isolated from 
10 ml blood by gradient centrifugation,  and the 
genomic DNA was puriﬁ ed by phenol/chloroform 
extraction and ethanol precipitation.  Polymerase chain 
reaction (PCR) ampliﬁ cation for the ARIX and 
PHOX2B genes was performed as described previ-
ously [22,  23].  For the KIF21A gene,  6 sets of 
primers were used to amplify exons 8,  20,  and 21 
from 100 ng of genomic DNA.  PCR was carried out 
with AmpliTaq Gold DNA polymerase (Roche,  
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Fig. 1　 Pedigrees of 3 families with congenital superior oblique muscle palsy and genomic DNA nucleotide changes in ARIX and 
PHOX2B.  Members who underwent the genomic DNA analysis are indicated by a symbol “＋ ”.  Females are denoted by circles,  males by 
boxes,  unaﬀ ected females and males by open circles and boxes,  aﬀ ected females and males by closed circles and boxes.
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Branchburg,  NJ,  USA): initial denaturation at 95 °C 
for 15 min,  followed by 35 cycles at 94 °C for 40 sec,  
52 °C for 1 min,  and 72 °C for 1 min,  and a ﬁ nal 
extension at 72 °C for 10 min.  The sequences of the 
primers for ARIX,  PHOX2B,  and KIF21A are shown 
in Table 1.
　 The PCR products were puriﬁ ed with ExoSAP-IT 
(USB,  Cleveland,  OH,  USA) and used as a template 
for direct sequencing with the ABI 310 Genetic 
Analyzer (Perkin-Elmer,  Foster,  CA,  USA) using 
the BigDye Terminator Cycle Sequencing Kit 
(Perkin-Elmer).  Both strands were sequenced for each 
DNA fragment.  The DNA sequences were aligned 
with the published human ARIX sequences (GenBank 
Accession Numbers: AF022722,  AF022723,  and 
AF022724),  PHOX2B sequence (GenBank Accession 
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Fig. 2　 Eye deviations in the daughter of Family No.  2.  Upward deviation of the left eye at the primary gaze position becomes greatest 
at the gaze toward the right,  namely,  at the nasal ﬁ eld of the aﬀ ected left eye.  Upward deviation of the left eye also becomes apparent 
when the head is tilted to the left side.
Table 1　 Sequences of primers used in polymerase chain reaction for ARIX,  PHOX2B,  and KIF21A gene ampliﬁ cation
Forward 5’-3’ Reverse 5’-3’
ARIX exon 1a TCCACACCTCTGAGCCCTAAGACGG GCCGCAGGGGGCTGTATTGGAAGC
ARIX exon 1b CCCCGGGCCGATGGACTACT AGCGGGCCCAGGGATTC
ARIX exon 2 CCCCGGAGCTGGACACAAC GCTCCCACACCTCCTTCCA
ARIX exon 3a GATCTCACTCGAGCCTTGC CTGCACGTGGACTCCTTGGA
ARIX exon 3b CGGGCCAAGTTCCGCAAACAGGAG GGAGTTTCTGGGGGCAGGCTCGGA
PHOX2B exon 1 GCGTTGAGCTGTGCACATCTC GCTTCCTATATACGGGCGG
PHOX2B exon 2 GAGTCCTCACATTCTAGCTCC CACTCGAGGCTCCAGGACTTCG
PHOX2B exon 3a GGCCACCCTAACCGGTGC CTGCTGCGCCGCCCTTG
PHOX2B exon 3b CCAGCTGCGGGGCGAATG CTGGCTCGCCCGCTGTC
KIF21A exon 8 TTTTAGCATTTTAGGTGCTTTT AAAGTGCCAGCCTTAGATGT
KIF21A exon 20 AAATGGCTCATTATTTGGCA CAGGGAACAAAATTGGAAGA
KIF21A exon 21 GGGGGTTTGATGGTACTGTAT CTTCATGTAAAAACTGAAAGTGCT
3
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Number: AF117979),  and KIF21A sequence 
(GenBank Accession Number: NT029419).
Results
　 Clinical features of the 3 families with congenital 
superior oblique muscle palsy are summarized in 
Table 2.  The father and daughter in Family No.  1 
shared congenital superior oblique muscle palsy while 
the mothers and daughters shared the palsy in 
Families No.  2 and No.  3.  The laterality of the supe-
rior oblique muscle involved in the palsy was the right 
side for both patients in Family No.1 and the left side 
for both in Family No.  2; by contrast,  the laterality 
of the palsy diﬀ ered between mother and daughter in 
Family No.  3 (Fig.  1).  The degrees of vertical devia-
tion were comparable between the aﬄ  icted members of 
each family.  Some members showed binocular fusion 
on the Bagolini striated glasses test and hence had 
measurable stereopsis at near vision while the others 
showed suppression or diplopia.
　 The atrophy of the superior oblique muscle was 
deﬁ ned as less than 50ｵ of the cross-sectional area of 
the muscle on the paralyzed side compared with the 
non-paralyzed side by magnetic resonance imaging [6].  
The father in Family No.  1 and the mother in family 
No.  2 showed muscle atrophy while the daughter in 
Family No.  2 appeared to completely lack the supe-
rior oblique muscle.  In contrast,  the other patients 
had no atrophy (Fig.  3).  The mother of Family No.  3 
did not undergo magnetic resonance imaging.
　 Gene polymorphisms detected in this study are 
summarized in Fig.  1.  ARIX gene heterozygous poly-
morphism in the 5’-untranslated region,  153G＞A 
(Fig.  4),  was found in common in the father and 
daughter of Family No.  1 and also in the mother and 
daughter of Family No.  3.  In contrast,  the aﬄ  icted 
members of Family No.  2 did not have this polymor-
phism.  The heterozygous amino acid-preserving poly-
morphism of exon 3 of the PHOX2B gene (Fig.  4),  
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Table 2　 Clinical characteristics of patients with congenital superior oblique muscle palsy in 3 families
Family
No. Member
Age at 
ﬁ rst 
visit
(years)
Laterality 
of SO 
palsy
Dominant
eye
Abnormal 
head
posture
Deviation
at 5 m
(prism 
diopter)
Bagolini striated 
glasses test
TNO
Test
(second 
of arc)
Surgical
procedure
SO
atrophy
by MRIat 5 m at 0.3 m
1 Father 54 Right Right Head tilt to 
Left
RHT30 Fusion Diplopia Absent LIR 
recession
Yes
10 degrees 6X 4 mm
Daughter 24 Right Right Head tilt to 
Left
RHT25 Fusion Fusion 60 RIO 
recession
No
5ﾝ10 
degrees
10X
2 Mother 33 Light Right Head tilt to 
Right
LHT20 Left eye Left eye Absent No 
surgery
Yes
10 degrees 6X suppression suppression
Daughter 2 Light Right Head tilt to 
Right
20 degrees
LHT25
12ET
＊unknown ＊unknown Absent LIO 
recession
Yes 
(SO 
Absence)
3 Mother 48 Right Light Head tilt to 
Left
RHT14 Right eye Fusion 60 RIO 
recession
Not done
5ﾝ10 
degrees
10X suppression
Daughter 14 Light Right Head Tilt to 
Right
LHT12 Right eye Fusion 240 No 
surgery
No
5 degrees 16XT suppression
ET,  esotropia; LHT,  left hypertropia; LIO,  left inferior oblique muscle; LIR,  left inferior rectus muscle; MRI,  magnetic resonance 
imaging; RHT,  right hypertropia; RIO,  right inferior oblique muscle; SO,  superior oblique muscle; X,  exophoria; XT,  exotropia.  
＊unknown due to the young age of subject.
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1121A＞C,  was detected only in the father of family 
No.  1 and the daughter of Family No.  3.  The daugh-
ter with congenital superior oblique muscle palsy in 
Family No.  2 had a heterozygous 15-base pair dele-
tion encompassing 1ｳ124 to 1ｳ138 of the PHOX2B gene,  
resulting in loss of 5 alanine residues in the alanine 
repeat (Fig.  5).  This PHOX2B 15-base pair deletion 
derived from the apparently normal father,  but not 
from the mother with congenital superior oblique 
muscle palsy.  The KIF21A gene polymorphisms,  
namely those in exons 8,  20 and 21,  were absent in all 
patients.
Discussion
　 The goal of this study was to search for the role of 
candidate genes in the development of congenital supe-
rior oblique muscle palsy in patients of 3 families.  
Family No.  1 has been included in genetic analysis in 
our previous reports [22,  23].  In this study,  we ana-
lyzed 2 additional families with congenital superior 
oblique muscle palsy.  We selected 3 genes,  ARIX,  
PHOX2B,  and KIF21A,  as candidate genes since 
KIF21A and ARIX were identiﬁ ed as causative genes 
for CFEOM type 1 [15,  16] and type 2 [19,  20],  
respectively.  Furthermore,  PHOX2B is a closely 
related counterpart of ARIX.  Both ARIX and 
PHOX2B are homeodomain proteins and expressed in 
the developmental process of the trochlear nuclei in 
the brainstem [24,  25].  KIF21A encodes a kinesin 
motor involved in anterograde axonal transport [15,  
16].  We also suppose that congenital superior oblique 
muscle palsy might be a milder clinical variant of 
CFEOM.
　 We described in this study clinical features of 3 
families with congenital superior oblique muscle palsy 
(Fig.  2 and Table 2).  The present study is the ﬁ rst to 
describe a series of families with congenital superior 
oblique muscle palsy in the Japanese population.  The 
laterality of the muscle palsy was the same in the 2 
49Congenital Superior Oblique Muscle PalsyFebruary 2008
Family No. 1
Daughter
Family No. 2
Daughter
Family No. 3
Daughter
Family No. 1
Father
Family No. 2
Mother
Fig. 3　 Magnetic resonance imaging in three families with congenital superior oblique muscle palsy.  Arrows in the father of Family No. 1 
and the mother of Family No.  2 show more than 50% atrophy of the muscle cross section compared with the opposite side.  The daughter 
in Family No.  2 appears to lack the muscle entirely (arrow).  The daughter in Family No.  3 has no atrophy (arrow) and the mother in Family 
No.  3 did not undergo magnetic resonance imaging.
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Forward sequence
PHOX2B 15-nucleotide deletion
Fig. 5　 Electropherogram of the forward sequence,  showing a heterozygous PHOX2B 15-base pair deletion encompassing 1,124 to 
1,138,  resulting in loss of 5 alanine residues in the alanine repeat,  in the daughter of Family No.  2.  The starting point of the deletion is 
noted by an arrow.
Wild type
Reverse sequence Reverse sequence
ARIX PHOX2B
Wild type153G＞A 1121A＞C
Fig. 4　 Electropherograms of the reverse sequences,  showing the heterozygous ARIX polymorphism,  153G＞A,  and the heterozygous 
PHOX2B polymorphism,  1121A＞C.  ARIX wild type,  mother of Family No.  2; ARIX 153G＞A,  mother of Family No.  3; PHOX2B wild 
type,  eldest daughter of Family No.  1; PHOX2B 1121A＞C,  father of Family No.  1.
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aﬄ  icted members of 2 families (Families No.  1 and 
No.  2),  but on opposite sides in the 2 aﬄ  icted mem-
bers of the other family (Family No.  3).  All 6 patients 
showed head tilt to the opposite side of the palsy 
muscle.  The degrees of vertical deviation were com-
parable between patients in the same family.  However,  
the levels of binocular vision such as fusion and stere-
opsis were variable.  Atrophy of the superior oblique 
muscle,  revealed by magnetic resonance imaging,  was 
not necessarily consistent between the patients within 
families.  Previous reports from other countries have 
described the same or inconsistent laterality of the 
superior oblique muscle palsy within families [10ﾝ
14].
　 A heterozygous nucleotide change in ARIX,  
153G＞A,  was found in common in the patients of 2 
families (Family No.  1 and No.  3) while this nucleo-
tide change was not found in the patients of the third 
family (Family No.  2).  In our previous studies [22,  
23],  the ARIX 153G＞A polymorphism has been 
found in normal Japanese individuals and also in 
patients with congenital superior oblique muscle palsy,  
though the rate of the ARIX 153G＞A polymorphism 
was signiﬁ cantly higher in patients with congenital 
superior oblique muscle palsy than in normal individu-
als.  The ARIX 153G＞A polymorphism might have 
been a genetic risk factor in the development of con-
genital superior oblique muscle palsy in the 2 families 
of this study.  A major drawback for this reasoning is 
the fact that the ARIX gene changes were not exam-
ined in all normal members in the families.  
Furthermore,  Family No.  2,  which lacked the ARIX 
153G＞A polymorphism,  might harbor other poly-
morphisms in the introns or upstream regions of the 
gene that were not sequenced in this study. 
　 Congenital superior oblique muscle palsy some-
times occurs on both sides and shows smaller vertical 
deviations at the primary gaze position.  Even in bilat-
eral involvement,  clinical clues such as the presence 
of large torsional deviations will help establish the 
diagnosis.  In Family No.  1,  the youngest daughter 
with normal traits harbored the ARIX 153G＞A poly-
morphism (Fig.  1),  but bilateral superior oblique 
muscle palsy was ruled out by clinical examinations 
[22,  23].  In general,  it is considered more plausible 
to have bilateral involvement of superior oblique 
muscle palsy in the presence of the ARIX gene poly-
morphism.  The explanation for the frequent unilateral 
involvement would be that gene dosage or expression 
might diﬀ er between the right side and the left side.
　 A heterozygous 15-nucleotide deletion in the 
PHOX2B gene,  1124del15,  was found in the daughter 
with congenital superior oblique muscle palsy in 
Family No.  2.  This deletion was not found in the 
mother with the muscle palsy but was found in the 
father without the muscle palsy.  The inconsistent 
segregation of the PHOX2B deletion with the muscle 
palsy indicates that the 15-nucleotide deletion is not 
responsible for the development of the congenital 
superior oblique muscle palsy in this family.  The 
same 15-nucleotide deletion in the PHOX2B gene was 
discovered in normal Japanese individuals and also in 
patients with schizophrenia and exotropia [26].  In 
that study,  the 15-nucleotide deletion was concluded 
not to be associated with the development of exotropia 
in schizophrenic patients [26].  The 15-nucleotide 
deletion in PHOX2B results in the loss of 5 alanine 
residues in the alanine repeat of the protein,  and the 
protein function remains at the 60ｵ level of normal 
counterparts.  Therefore,  this deletion would not nec-
essarily exert marked inﬂ uence.
　 Single nucleotide changes,  insertions,  and dele-
tions in PHOX2B were also found in neuroblastoma,  
Hirschsprung’s disease,  and congenital central 
hypoventilation syndrome [27ﾝ31].  The single nucleo-
tide changes result in amino acid substitution.  The 
deletions are not in units of 3 nucleotides; hence,  they 
result in frame shift mutations.  The insertions are in 
units of 3 nucleotides and result in the addition of 
alanine residues in the alanine repeat.  In contrast with 
alanine residue loss,  alanine residue addition caused 
marked loss of the protein function [26].
　 The single nucleotide change in the PHOX2B gene,  
1121A＞C,  resulting in no amino acid substitution,  
was found in 2 separate patients with congenital supe-
rior oblique muscle palsy in diﬀ erent families in this 
study.  In our previous study,  PHOX2B 1121A＞C 
was found only in patients with congenital superior 
oblique muscle palsy and not in normal individuals,  
suggesting that PHOX2B 1121A＞C might be a 
genetic risk factor for the development of congenital 
superior oblique muscle palsy [23].  Nevertheless,  in 
this study,  the PHOX2B 1121A＞C polymorphism did 
not segregate with the muscle palsy in the families,  
suggesting that this change might not be a genetic risk 
factor for the development of congenital superior 
51Congenital Superior Oblique Muscle PalsyFebruary 2008
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oblique muscle palsy.
　 The patients of the three families did not harbor 
any nucleotide changes in the analyzed exons 8,  20,  
and 21 of KIF21A.  We analyzed these 3 exons by 
sequencing since so far the mutations found in patients 
with CFEOM type 1 have resided in these exons [15ﾝ
18].  Therefore,  we cannot exclude the possibility 
that other exons of KIF21A harbor nucleotide changes.  
KIF21A gene mutations have been found in CFEOM 
type 1,  which involves primarily the oculomotor 
nerve,  but not the trochlear nerve [15ﾝ18].  Based on 
this fact,  the KIF21A gene might basically play a 
minor role in congenital superior oblique muscle palsy,  
which is caused by trochlear nerve impairment.
　 In conclusion,  we present the clinical characteris-
tics of patients with congenital superior oblique mus-
cle palsy in 3 families,  and analyzed candidate genes 
in the patients of these families.  The ARIX 153G＞A 
polymorphism was found in common between the 
patients in 2 families and might be a genetic risk for 
the development of congenital superior oblique muscle 
palsy.  A PHOX2B gene 15-nucleotide deletion,  found 
in 1 patient of the other family (Family No.  2),  is not 
considered responsible for the development of con-
genital superior oblique muscle palsy.  Unknown poly-
morphisms in the ARIX gene,  or polymorphisms in the 
other genes,  for instance,  involved in the formation of 
the extraocular muscle,  might play a role in the muscle 
palsy in this family.
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